4//SEC Filing
Buell Jennifer 4
Accession 0001493152-24-012071
CIK 0001022899other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 9:29 PM ET
Size
457.4 KB
Accession
0001493152-24-012071
Insider Transaction Report
Form 4
Buell Jennifer
Director
Transactions
- Award
PTIX Common stock Options
2024-03-25$1.74/sh+75,000$130,500→ 75,000 totalExercise: $1.74Exp: 2034-03-25→ PTIX Common Stock, Par Value $0.0001 (75,000 underlying)
Footnotes (1)
- [F1]50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable.
Documents
Issuer
Protagenic Therapeutics, Inc.\new
CIK 0001022899
Entity typeother
Related Parties
1- filerCIK 0001711184
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 9:29 PM ET
- Size
- 457.4 KB